Dopamine Agonists: Clinical Trials

5 trials of Dopamine Agonists, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1

Follow Dopamine Agonists: new trials by email Literature Review of Dopamine Agonists trials Research Report on Dopamine Agonists

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Carbergoline for Antipsychotic Induced Hyperprolactinemia.
Cabergoline (Dopamine Agonist), Placebo - Scizophrenia
Phase 4Not yet recruitingZealand University Hospital1462026-05-012026-02-04
Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
Cabergoline (Dopamine Agonist) - Prolactinoma
Phase 4RecruitingUniversity Hospital, Basel, Switzerland602025-09-162025-09-23
Pramipexole for Restless Leg Syndrome in Peritoneal Dialysis Patients
Pramipexole, placebo - Restless Legs Syndrome
Phase 4TerminatedDong Jie212019-07-012021-12-09
PRolaCT - Three Prolactinoma RCTs
Endoscopic trans-sphenoidal adenoma resection, Dopamine Agonists - Prolactinoma, Prolactin-Producing Pituitary Tumor
Phase 4UnknownLeiden University Medical Center8802019-06-212020-07-20
Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa
Levodopa/Carbidopa(200mg/50mg), Dopaminergic Agonists - Impulse Control Disorder
Phase 4CompletedSandoz1502012-11-012021-03-10

Conditions studied

Prolactinoma (2)  ·  Disruptive, Impulse Control, and Conduct Disorders (1)  ·  Hyperprolactinemia (1)  ·  Prolactin Deficiency, Isolated (1)  ·  Restless Legs Syndrome (1)

Sponsors

Dong Jie (1)  ·  Leiden University Medical Center (1)  ·  Sandoz (1)  ·  University Hospital, Basel, Switzerland (1)  ·  Zealand University Hospital (1)

Countries

China (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  South Korea (1)  ·  Switzerland (1)

Top investigators

Cihan Atila, Dr. (1)  ·  Jesper Krogh (1)  ·  Jie Dong (1)  ·  Jinwhan Cho, MD (1)  ·  Nienke R Biermasz, MD, prof. (1)  ·  Wouter R van Furth, MD, PhD (1)

Results publications

PMID 30361296, PMID 32075834, PMID 34563236

NIH funding

2025 (1)